News | June 15, 2012

First Patient Active with Latitude NXT Remote Patient Management System

Next-generation wireless remote patient management system enabled for Ingenio family of pacemakers is now in use in Europe

June 15, 2012 — Boston Scientific Corp. has initiated use of the Latitude NXT Remote Patient Management System with patients who have implantable electrophysiology devices in Europe.

Dr. Roberto Verlato, head of cardiology at Camposampiero Hospital in Verona, Italy initiated use of the Latitude NXT system with a patient implanted with an Ingenio SR pacemaker, and provided the patient with a new home-based wireless communicator. 

“We welcome the next-generation Latitude NXT system as it provides pacemaker patients with a simple and easy-to-use communicator that may replace certain in-clinic follow-up visits.  The system offers clinicians the most comprehensive suite of diagnostic tools in the CRM [cardiac rhythm management] industry  to support proactive treatment decisions and provide an opportunity to verify improvement of clinical outcomes, as was demonstrated for ICD [implantable cardioverter defibrillator] and CRT-D [cardiac resychronization therapy defibrillator] patients in the ALTITUDE Survival study,” said Verlato.

The Latitude NXT website and patient communicator merge key features from the Latitude system with new features requested by physicians and patients, and is fully compatible with Boston Scientific’s advanced pacemaker family: Ingenio and Advantio pacemakers and INVIVE cardiac resynchronization therapy pacemakers (CRT-P).  

Latitude NXT offers patients a simplified experience with wireless and automatic remote follow-up and optional integrated cellular GSM connectivity, providing patients with greater convenience than existing systems. In addition, it features a unique communicator-initiated device interrogation which is designed to minimize impact on implanted device battery longevity, potentially giving patients greater peace of mind.

Latitude NXT offers health care professionals a system that provides convenient online access to relevant pacemaker patient information, and flexibility and control in how clinicians receive and review data. The system features alert notification options such as SMS message or email, simple website administration, and integration with the electronic medical records (EMR) to automate hospital workflow — which could save up to 15 minutes for each patient transmission, the average time it takes to manually enter routine device follow-up data into an EMR system.

Latitude NXT is compatible with the wireless weight scale and blood pressure monitor from Boston Scientific.  Physicians can choose to remotely monitor a series of relevant health status indicators including weight and blood pressure, as well as respiratory and sleep apnea trending. By providing access to this diagnostic information, Latitude NXT enables physicians to risk-stratify patients to more confidently make informed, proactive treatment decisions.

Pacemakers are designed to treat bradycardia, a condition in which the heart beats too slowly – usually less than 60 beats per minute – depriving the body of sufficient oxygen.

The Latitude NXT remote patient management system is currently under review by the U.S. Food and Drug Administration and is currently not available for sale in the United States.

For more information: www.bostonscientific.com

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Overlay Init